A Streamlined Process to Phenotypically Profile Heterologous cDNAs in Parallel Using Yeast Cell-Based Assays

AUTOR(ES)

Tugendreich, Stuart

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

To meet the demands of developing lead drugs for the profusion of human genes being sequenced as part of the human genome project, we developed a high-throughput assay construction method in yeast. A set of optimized techniques allows us to rapidly transfer large numbers of heterologous cDNAs from nonyeast plasmids into yeast expression vectors. These high- or low-copy yeast expression plasmids are then converted quickly into integration-competent vectors for phenotypic profiling of the heterologous gene products. The process was validated first by testing proteins of diverse function, such as p38, poly(ADP-ribose) polymerase-1, and PI 3-kinase, by making active-site mutations and using existing small molecule inhibitors of these proteins. For less well-characterized genes, a novel random mutagenesis scheme was developed that allows a combination selection/screen for mutations that retain full-length expression and yet reverse a growth phenotype in yeast. A broad range of proteins in different functional classes has been profiled, with an average yield for growth interference phenotypes of ∼30%. The ease of manipulation of the yeast genome affords us the opportunity to approach drug discovery and exploratory biology on a genomic scale and shortens assay development time significantly.

Documentos Relacionados

• mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity
• A Cell-Based Approach for Diabetes Treatment Using Engineered Non-β Cells
• Adult mesenchymal stem cells and cell-based tissue engineering
• Use of viral promoters in mammalian cell-based bioassays: How reliable?
• A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions